Sort
1,049,261 grants matching “t cell”
PREVENTION OF LETHAL METASTATIC BREAST CANCER BY IDENTIFYING AND ERADICATING CLINICALLY RELEVANT DISSEMINATED TUMOR CELLS
$11,719,011Fred Hutchinson Cancer Center · · FY2022 · Department of the Army
Development of immunology and immunization strategies that induce broadly pro
$11,675,740Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2014 · AI
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis
$11,665,635James Dale Berry · Massachusetts General Hospital · U01 · FY2024 · NS
Novel Dopamine D3/D2 Receptor Ligands
$11,662,952Amy Hauck Newman · National Institute On Drug Abuse · ZIA · FY2023 · DA
Maintenance and Improvement of NINDS Infrastructure
$11,654,012Alan Koretsky · National Institute Of Neurological Disorders And Stroke · ZIC · FY2010 · NS
Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS).
$11,639,047Jinsy Andrews · New York University School Of Medicine · U01 · FY2025 · NS
Administrative Supplement 2: The Midwest Center for Cryo-Electron Tomography
$11,634,724Elizabeth R Wright · University Of Wisconsin-Madison · U24 · FY2023 · GM
Adult Changes in Thought (ACT) Research Program
$11,629,456Linda Kathleen McEvoy · Kaiser Foundation Research Institute · U19 · FY2025 · AG
Center for Alzheimer's and Related Dementias (CARD): Harmonized Data-Derived Resources for the Alzheimer's Disease and Related Dementias Community
$11,628,452Andrew Singleton · National Institute On Aging · ZIA · FY2022 · AG
Cancer Center Support Grant
$11,605,201Harold E Varmus · Sloan-Kettering Inst Can Research · P30 · FY2007 · CA
Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS).
$11,593,647Jinsy Andrews · Columbia University Health Sciences · U01 · FY2024 · NS
Infectious Diseases Research Technologies Core - Bethesda
$11,590,281Robert Hohman · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
INTEGRATING CELL-FREE SYSTEMS AND GENOME ENGINEERING TO ACCELERATE BIOSYSTEMS DESIGN FOR CARBON-NEGATIVE BIOMANUFACTURING
$11,582,563Northwestern University · · FY2022 · Department of Energy
DCTD Biopharmaceutical Development
$11,541,306Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
Inner City Asthma consortium 3 (ICAC3)
$11,536,127William W. Busse · University Of Wisconsin-Madison · UM1 · FY2017 · AI
Center for Alzheimer's and Related Dementias (CARD): iPSC Neurodegenerative Diseases Initiative
$11,535,848Andrew Singleton · National Institute On Aging · ZIA · FY2021 · AG
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes
$11,528,656Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA
Targeting SS18-SSX biology in synovial sarcomagenesis
$11,520,799Kevin Bruce Jones · University Of Utah · U54 · FY2018 · CA
NIMH Center for Collaborative Genetic Studies
$11,514,895Jay Arnold Tischfield · Rutgers, The State Univ Of N.J. · U24 · FY2010 · MH
Cancer and Leukemia Group B
$11,457,918Richard L Schilsky · University Of Chicago · U10 · FY2009 · CA
Laboratory, Data Analysis and Coordinating Center (LDACC)
$11,456,269 · N01 · FY2010 · HL
DCTD Human Toxicology and Pharmacology
$11,440,830David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
Cancer Center Support Grant (Comprehensive)
$11,373,047Lawrence Corey · Fred Hutchinson Cancer Research Center · P30 · FY2012 · CA
Cancer Center Support Grant (Comprehensive)
$11,342,319Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2010 · CA
Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery
$11,276,777Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2017 · AI